Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Myovant Sciences Ltd. | myovant10kmarch312020.htm |
| EX-32.2 - EXHIBIT 32.2 - Myovant Sciences Ltd. | myovantex3223312020.htm |
| EX-32.1 - EXHIBIT 32.1 - Myovant Sciences Ltd. | myovantex3213312020.htm |
| EX-31.2 - EXHIBIT 31.2 - Myovant Sciences Ltd. | myovantex3123312020.htm |
| EX-31.1 - EXHIBIT 31.1 - Myovant Sciences Ltd. | myovantex3113312020.htm |
| EX-21.1 - EXHIBIT 21.1 - Myovant Sciences Ltd. | myovantex2113312020.htm |
| EX-10.24 - EXHIBIT 10.24 - Myovant Sciences Ltd. | myovantex10243312020.htm |
| EX-10.6 - EXHIBIT 10.6 - Myovant Sciences Ltd. | myovantex1063312020.htm |
| EX-10.5 - EXHIBIT 10.5 - Myovant Sciences Ltd. | myovantex1053312020.htm |
| EX-10.4 - EXHIBIT 10.4 - Myovant Sciences Ltd. | myovantex1043312020.htm |
| EX-4.1 - EXHIBIT 4.1 - Myovant Sciences Ltd. | myovantex413312020.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
(1) | Registration Statement (Form S-8 No. 333-233059) pertaining to the 2016 Equity Incentive Plan; |
(2) | Registration Statement (Form S-3ASR No. 333-231764); |
(3) | Registration Statement (Form S-8 No. 333-228277) pertaining to the 2016 Equity Incentive Plan; |
(4) | Registration Statement (Form S-3 No. 333-221526); and |
(5) | Registration Statement (Form S-8 No. 333-218057) pertaining to the 2016 Equity Incentive Plan |
of our report dated May 18, 2020, with respect to the consolidated financial statements of Myovant Sciences Ltd. included in this Annual Report (Form 10-K) of Myovant Sciences Ltd. for the year ended March 31, 2020.
/s/ Ernst & Young LLP
Redwood City, California
May 18, 2020